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Objective: Involvement of the pancreato-biliary system has been occasion-
ally noted in Henoch-Scho¨nlein purpura. Furthermore, cases of this vascu-
litis syndrome sometimes develop in the context of a viral hepatitis or after
hepatitis vaccination.
Methods: We completed a review of the literature.
Results: Fifty reports published between 1977 and 2015 were retained for
the analysis. A pancreato-biliary involvement was recognized in 34
individually well-described patients (<:,¼ 19:15) with severe
abdominal pain: pancreatitis (N¼ 20), acalculous cholecystitis (N¼ 11),
both pancreatitis and cholecystitis (N¼ 3). In all of the pancreatitis
patients, full recovery occurred (within 3 weeks in three-fourths of the
patients). Cholecystectomy was performed in 8 cholecystitis patients.
Seventeen Henoch-Scho¨nlein patients (<:,¼ 9:8) were associated with
a viral liver disease and 4 (<:,¼ 1:3) with a hepatitis vaccination. The
vasculitis syndrome rapidly remitted in the 7 patients accompanying
hepatitis A or E, in 2 patients of hepatitis B, and in the 4 patients
preceded by a vaccination. Henoch-Scho¨nlein purpura seemed to be
serious in 5 patients with chronic hepatitis B and in 3 with chronic
hepatitis C.
Conclusions: This analysis indicates that pancreato-biliary involvement is
unusual in Henoch-Scho¨nlein purpura. This complication deserves
consideration in patients with especially severe abdominal pain. Finally,
viral hepatitides and hepatitis vaccinations seem to be rare triggers of
Henoch-Scho¨nlein purpura.Key Words: acalculous cholecystitis, Henoch-Scho¨nlein purpura,
hepatitis, kidney disease, pancreatitis, vaccination
(JPGN 2016;62: 457–461)H enoch-Scho¨nlein purpura, also known as immunoglobulinA leukocytoclastic vasculitis, is usually triggered by an
infectious disease or, more rarely, a vaccination (1). This condition
characteristically presents with palpable purpura concentratedPancreatitis and acalculous cholecystitis are unusual
but recognized complications of abdominal vasculitides. Unsurpris-
ingly, therefore, involvement of the pancreato-biliary system has
been occasionally noted in Henoch-Scho¨nlein purpura. Moreover,
cases of this vasculitis sometimes develop either in the context
of an acute or chronic viral liver disease or after hepatitis A or B
vaccination. Because textbooks and reviews only marginally men-
tion these associations, we reviewed and analyzed the available
literature.
METHODS
Between February and May 2015, we performed a com-
puter-based search with no date limits of the terms (Henoch OR
Scho¨nlein OR Henoch-Scho¨nlein OR Scho¨nlein-Henoch OR
anaphylactoid purpura OR rheumatoid purpura OR rheumatoid
angiitis OR vasculitis) AND (liver OR hepatic OR biliary OR
pancreatic OR hepatitis OR vaccination) in the search engine
PubMed. In addition, we used our personal files and the bibli-
ography of each identified study. We applied the principles
established by the Economic and Social Research Council gui-
dance on the conduct of narrative synthesis and on the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
statement (2). For the final analysis, we selected peer-reviewed
reports published as full-length article or letter, which include
Henoch-Scho¨nlein patients with pancreas, gallbladder, or liver
involvement. Cases of this vasculitis syndrome associated with a
viral liver disease or preceded by a vaccination against hepatitisduction of this article is prohibited.
re also selected. We exclusively retained
inal cases presenting subjects of both
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Cosexes and all ages irrespective of follow-up duration, which had
been published in Dutch, English, French, German, Italian,
Portuguese, or Spanish. When >1 article reported on the same
patient, only the more comprehensive article was included and
referenced.
The diagnosis of Henoch-Scho¨nlein purpura, pancreatitis,
and cholecystitis established in the original publications, which
were often supported by figures depicting skin lesions and imaging
studies, was reviewed using recognized criteria. The diagnosis of
Henoch-Scho¨nlein purpura was based on the European League
Against Rheumatism/Paediatric Rheumatology International Trials
Organization/Paediatric Rheumatology European Society criteria
(3). The latter include palpable purpura together with at least 1 of
the following findings: abdominal pain, leukocytoclastic vasculitis
with immunoglobulin A (IgA) deposits, acute arthritis, or arthralgia
in any joint and renal involvement as evidenced by pathological
urinalysis, with or without a biopsy disclosing mesangial IgA
deposits (3). The diagnosis of pancreatitis was made in patients
with abdominal pain and amylase or lipase level at least twice the
upper limit of normal in the absence of alcohol abuse, gallstones, or
prescription of drugs implicated as causing pancreatitis (4). The
diagnosis of acalculous cholecystitis was made in patients with right
upper quadrant abdominal pain and imaging studies disclosing a
significant (4 mm) gallbladder wall thickening (with or without
fluid collection around the gallbladder) in the absence of alternative
diagnoses such as calculous cholecystitis (5). The diagnosis of
hepatitis A, B, or C was made using standard laboratory techniques.
Henoch-Scho¨nlein cases associated with infectious mononucleosis,
Bianchetti et alpyright 2016 by ESPGHAN and NASPGHAN. Un
primary biliary cirrhosis or alcohol abuse, as well as with docu-
mented causes of pancreatitis or cholecystitis, were excluded.
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458From each report dealing with Henoch-Scho¨nlein purpura
and pancreato-biliary involvement or viral liver disease or vaccina-
tion, we excerpted data on sex, age, presence of abdominal pain
preceding the purpura, aminotransferase levels, kidney disease,
course, and management. The data were extracted by 2 investigators
(R.H. and S.A.G.L.) independently and a consensus was reached on
all items. Disagreements were resolved through discussion or
adjudicated by a third author (G.P.M.).
The kidney disease was classified as absent in patients with
normal urinalysis, mild in patients with hematuria and urine protein/
creatinine ratio <200 g/mol, moderate in patients with hematuria
and protein/creatinine ratio>200 g/mol, and severe in patients with
protein/creatinine ratio >200 g/mol, hypoalbuminemia (<25 g/L),
and pitting edema (6).
Results are given either as frequency or as median and
interquartile range. The Fisher exact test was used to compare
dichotomous variables and the Mann-Whitney-Wilcoxon rank-sum
test to compare continuous variables. Statistical significance was
assigned at P < 0.05.
RESULTS
Search Results
A total of 50 peer-reviewed scientific reports (7–57)
published between 1977 and 2015 in English (N¼ 41), French
(N¼ 4), German (N¼ 2), Spanish (N¼ 2), and Italian (N¼ 1)
were retained for the final analysis (Fig. 1). They had been
reported from the following continents: Asia (N¼ 22), Europe
JPGN  Volume 62, Number 3, March 2016authorized reproduction of this article is prohibited.
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severe respectively a moderate kidney disease occurred in each
1 of the 2 remaining patients, who were affected with a chronic
TABLE 1. Characteristics of 34 Henoch-Scho¨nlein patients with bilio-pancreatic involvement
All Pancreatitis Cholecystitis Pancreatitis þ cholecystitis
N 34 20 11 3
Age, y 15 (7–43) 17 (8–47) 8 (5–35) 6, 8, 30

Sex, <: , 19: 15 11: 9 6: 5 2: 1
Abdominal pain precedes purpura, N (%) 14 (41) 11 (55) 2 (18) 1 (33)
Aminotransferases elevated, N (%) 11 (32) 5 (25) 4 (36) 2 (67)
Kidney disease, N (%) 17 (50) 10 (50) 5 (45) 2 (67)
Mild 8 3 4 1
Moderate 3 3 0 0
Severe 6 4 1 1
Results are given as either frequency or median and interquartile range (7–38).
TABLE 2. Cases of Henoch-Scho¨nlein syndrome associated (40–57)
with a viral liver disease (N¼17) or preceded by hepatitis A or B
vaccination (N¼4)
Trigger N Age

Sex (<: ,)
Viral liver disease
Hepatitis B 7 3.0, 6, 8, 13, 23, 32, 40 2: 5
Hepatitis A 6 2.7, 8, 10, 10, 11, 13 4: 2
Hepatitis C 3 50, 63, 56 3: 0
Hepatitis E 1 6 0: 1
Vaccination
Hepatitis A 2 1.6, 24 1:1
Hepatitis B 2 21, 28 0:2
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(7–38), 17 patients associated with a viral liver disease (39–52)
and 4 preceded (53–56) by a hepatitis vaccination. Using the
aforementioned inclusion criteria, we always confirmed the diag-
nosis of Henoch-Scho¨nlein purpura, pancreatitis, or cholecystitis
established in the original publications.
Pancreato-Biliary Involvement
Pancreatitis (7–25) was recognized in 20, acalculous cho-
lecystitis (26–35) in 11, and both pancreatitis and cholecystitis
(36–38) in 3 individually well-described patients. A kidney disease
was noted in 17 of the 34 patients (Table 1). Patients with kidney
involvement were significantly older by 21 years than those without
(28 [16–52] vs 7 [5–12] years, P< 0.01). Abdominal pain, which
was associated with arthralgia or arthritis in 8 patients, preceded the
appearance of purpura by 2 weeks in 14 of the 34 Henoch-
Scho¨nlein patients with pancreato-biliary involvement.
Pancreatitis
In addition to the increased amylase or lipase tests, the
pancreas appeared diffusely enlarged and hypoechoic on abdominal
ultrasound in 8 of the 20 pancreatitis patients. Peripancreatic fluid
and bowel wall thickening were noted in 7 and in 5 patients,
respectively. Finally, cardiac failure (19) and acute respiratory
distress syndrome (11) were observed in each 1 patient. Sympto-
matic and supportive management was provided in all patients.
Steroids were given in 7 patients. In all of the patients, full recovery
occurred (within 3 weeks in 3/4 of the patients). It is true,
however, that in 2 patients the clinical remission was observed 3
to 4 months after the diagnosis.
Cholecystitis
Cholecystectomy (open surgery, N¼ 6; laparoscopic
surgery, N¼ 2) was performed in 8 of the 11 patients affected
with cholecystitis. The intraoperative diagnosis of gallbladder
perforation with biliary peritonitis was made in 1 patient (34).
Supplemental bile duct stenosis leading to severe secondary chole-
static liver disease was noted in 1 further patient (31). Finally,
cholecystitis was associated with intussusception in 1 patient (35).
Cholecystitis and Pancreatitis
Individual values.pyright 2016 by ESPGHAN and NASPGHAN. Un
None of the 3 patients with concurrent involvement of
gallbladder and pancreas underwent surgery. In 1 of these patients,
www.jpgn.orga ureteric obstruction was also observed (36). The bilio-pancreatic
involvement resolved after10 days in 2 and approximately after 4
months in the patient with ureteric obstruction (steroids had been
given in this patient).
BIOPSY STUDIES
A skin biopsy, performed in 12 patients with pancreatitis, in 3
with cholecystitis, and in 2 with both cholecystitis and pancreatitis,
showed a leukocytoclastic vasculitis with IgA deposits. A kidney
biopsy, performed in 7 patients with pancreatitis, revealed mesan-
gial IgA deposits. Histopathology of gallbladder, performed in 7
patients with 2, revealed a leukocytoclastic vasculitis in 4 patients
and the distinctive signs of cholecystitis in the remaining 3 patients.
Henoch-Scho¨nlein Purpura Associated With a
Viral Liver Disease or Preceded by Hepatitis
Vaccination
The literature included also 17 Henoch-Scho¨nlein cases
associated with an acute or chronic viral liver disease (39–52)
and 4 preceded (53–56) by a hepatitis vaccination (Table 2).
Henoch-Scho¨nlein purpura spontaneously resolved within
4 weeks in the 7 cases accompanying hepatitis A or E and in
the 4 cases preceded by vaccination against hepatitis A or B. No
kidney disease was observed in these 11 patients.
Henoch-Scho¨nlein purpura spontaneously resolved without
any kidney disease in 5 of 7 hepatitis B patients. These patients also
rapidly and spontaneously recovered from the liver disease. Aauthorized reproduction of this article is prohibited.

Individual values.
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Cohepatitis B (no follow-up information is available for these
patients).
In the 3 patients with chronic hepatitis C (2 of them com-
plicated by liver cirrhosis), Henoch-Scho¨nlein purpura presented
in each 1 patient without, with mild or with moderate kidney
disease. The long-term prognosis was predicted by the underlying
liver disease.
DISCUSSION
The present review indicates that in Henoch-Scho¨nlein pur-
pura there is rarely a clinically relevant pancreato-biliary involve-
ment. Furthermore, this condition is sometimes triggered by a viral
liver disease or preceded by a vaccination against hepatitis A or B.
It is assumed that the prognosis of Henoch-Scho¨nlein pur-
pura is essentially determined by the severity of the accompanying
kidney disease (1,6). This impression is supported by the present
analysis: in3/4 of the Henoch-Scho¨nlein patients with pancreato-
biliary involvement the disease was benign and self-remittent.
Ninety percent of Henoch-Scho¨nlein cases occur between
the ages of 3 and 15 years (1), cases with pancreato-biliary
involvement between the ages of 5 and 55 years. Recommended
management of pancreatitis includes proper fluid management, pain
relief, and nutritional support (4), that of acalculous cholecystitis
surgery and antibiotics (5). We speculate that steroids as well
deserve consideration in cholecystitis or pancreatitis that develops
in the context of a vasculitis syndrome. All the more so because in
Henoch-Scho¨nlein purpura steroids effectively treat abdominal
pain, which mostly results from bowel wall swelling and bleeding.
In a retrospective case series from the Republic of China
including 225 apparently unselected children with Henoch-
Scho¨nlein (57), imaging studies disclosed abnormalities of the
biliary system in 14 (6%) of them: gallbladder wall thickening
4 mm (N¼ 7), sludge (N¼ 5), gallbladder dilatation (N¼ 1), and
bile duct dilatation (N¼ 1). These data, which deserve further
confirmation, point to the possible existence, in some Henoch-
Scho¨nlein patients, of gallbladder abnormalities that may predis-
pose to acalculous cholecystitis.
Henoch-Scho¨nlein cases often develop after an upper
respiratory infection (1). Further infectious triggers include
Epstein-Barr virus, Helicobacter, Legionella, Mycoplasma, Parvo-
virus, Varicella zoster virus, or Yersinia (1). Cases also have been
reported following vaccination (1). The present analysis indicates
that viral hepatitides and vaccination against hepatitis A or B may
be further possible triggers of this vasculitis. The number of
reported Henoch-Scho¨nlein patients temporally associated with
viral hepatitides or vaccination against hepatitis is limited. It is
true, however, that most vasculitides associated with hepatitides or
vaccininations are ‘‘non–Henoch-Scho¨nlein vasculitides’’ (58).
Henoch-Scho¨nlein purpura that develops after vaccination against
hepatitis or in the context of hepatitides, which usually rapidly
resolve on their own, is benign and remits soon. On the contrary,
cases that develop in the context of chronic hepatitis B and C
may be serious. In the latter patients, the long-term prognosis is
essentially determined by the severity of the underlying liver
disease.
Some limitations of this work should be mentioned. First, it
results from the small number of reported patients, often without or
with a brief follow-up. Second, diagnostic and therapeutic recom-
mendations arise from authors’ opinions. Third, data on liver
involvement in patients not triggered by a viral liver disease are
inconsistent. Fourth, the relation between viral liver diseases
Bianchetti et alpyright 2016 by ESPGHAN and NASPGHAN. Un
respectively vaccinations against hepatitis A or B and Henoch-
Scho¨nlein purpura is so far undemonstrated.
460In conclusion, this analysis indicates that pancreato-biliary
involvement is unusual in this vasculitis. This complication
deserves consideration in patients with especially severe abdominal
pain. Testing for lipase and ultrasonic imaging by an examiner
aware of the diagnostic suspicion represents, in our opinion, the
most reliable diagnostic tools currently available for Henoch-
Scho¨nlein patients with suspected pancreato-biliary involvement.
Finally, the present analysis demonstrates that viral liver disease
and, to a lesser extent, hepatitis vaccinations may be rare triggers
of Henoch-Scho¨nlein purpura.
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